Patterns of serum-luteinizing hormone surges in stimulated cycles in relation to injections of human chorionic gonadotropin*
|
|
- Preston McGee
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY Copyright ov 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Patterns of serum-luteinizing hormone surges in stimulated cycles in relation to injections of human chorionic gonadotropin* Vera Baukloh, M.S. t Robert Fischer, M.D. OlafNaether, M.D. Heinz-G. Bohnet, M.D. Institute for Hormone and Fertility Research, Hamburg, Federal Republic of Germany Endogenous-luteinizing hormone (LH) surges may complicate the management of in vitro fertilization cycles. To investigate the effects of LH surges after hormonal stimulation 53 IVF cycles were analyzed by assessing LH levels three times daily until egg collection. In 43% the LH rise started before the planned exogenous trigger for ovulation was given, in 11% the rise occurred simultaneously with and in 45% after the injection of human chorionic gonadotropin. Three main patterns of serum LH surges were identified: (A) low-lh tonus with straight increase to maximum; (B) low tonus with elevation before straight increase; (C) high tonus with large variations but no prominant peak. These patterns were not related to the follicular estradiol increase, luteal steroid concentrations or resulting pregnancy rates. Fertil Steril53:69, 1990 The luteinizing hormone (LH) surge occurring in the natural cycle is the trigger for the final maturation of the metaphase II oocyte and for the initiation of follicular rupture. It occurs. after a sustained rise in estradiol (E 2) levels, with a slight decrease thereafter just before or concomitently with the onset of the LH surge. 1 This pattern has also been observed in gonadotropin-induced cycles, 2 3 although the LH surge is markedly attenuated. Several authors 4-6 have observed lower pregnancy rates after in vitro fertilization (IVF) and embryo transfer (ET) procedures in cases where an endogenous LH discharge was identified as compared with human chorionic gonadotropin (hcg) triggered cycles. This led to the policy of cancelling treat- Received March 13, 1989; revised and accepted August 24, *Supported by Serono Diagnostics, Freiburg, FRG. t Reprint requests: V. Baukloh, Institute for Hormone and Fertility Disorders, Lornsenstrasse 4, D-2000 Hamburg, Federal Republic of Germany. ment cycles with endogenous LH surges before hcg injection in many IVF groups. Luteinizing hormone has been shown to accelerate the final oocyte maturation in vitro by approximately one-half hour. 7 However, oocytes which had not been exposed to LH or to hcg have been reported by Templeton et al. 8 to show normal fertilization rates. Spontaneous LH surges occur in approximately 20% of cycles stimulated by clomiphene citrate (CC) plus human menopausal gonadotropin (hmg) The availability of monoclonal antibodies specific for LH enables distinction between endogenous LH and hcg administered for timed oocyte retrieval. We have therefore used a monoclonal antibody based radio-immuno assay (RIA) to determine serum LH profiles in IVF patients during CC plus hmg-treated cycles and have assessed the relationship between endogenous LH surges and the success rates of the therapy. MATERIALS AND METHODS From October 1987 to June 1988 a total of 151 patients were subjected to CC plus hmg stimula- Baukloh et al. Patterns of serum LH surges 69
2 tion for IVF therapy. In these 64 endogenous LH surges were observed, 30 occurred before the injection of hcg, and 34 at the same time as or after hcg administration. In 53 of these patients who completed their IVF cycle up to ET, serum LH concentrations were closely monitored around the time of expected LH surge (day 10 to 14 of the cycle). Blood samples were taken in the morning (7 A.M. to 8 A.M.), early afternoon (1 P.M. to 2 P.M.), and evening (10 P.M. to 12 P.M.) until the day of the follicular puncture. Luteinizing hormone concentrations were determined by RIA (LH Maiaclone, Serono Diagnostics, Freiburg, FRG). The interassay and intra-assay coefficients of variation were 7.7% and 5.0%, respectively, the lower limit of detection was 0.3 miu /ml. The assay exhibits very low cross-reactivity with hcg ( % at 5 IU/mL hcg). This high specificity allows the measurement of LH even after the injection of hcg for ovulation induction. The stimulation protocol was as follows: CC (Dyneric, Merrell Dow, Riisselsheim, FRG) 100 mg/d from day 2 of the cycle until day 6, hmg 150 IU per day (Pergonal, Serono) from day 5 until a sufficient ovarian response was achieved (at least three developing follicles~ 16 mm in diameter, and E2 at least 300 pg/ml per follicle ~ 16 mm) with daily monitoring starting on cycle day 8. In cases where hcg was injected before an LH surge oocyte collection was performed 36 hours later. If an endogenous LH surge was detected before the planned hcg injection follicular puncture was performed 30 hours after the first significant rise in serum LH levels. The onset of the LH surge was defined as the first point at which the serum LH exceeded the baseline level by at least two standard deviations. When an endogenous LH rise was observed an additional dose of 5000 IU hcg was given as soon as the surge onset was verified (2 to 10 hours after the first positive serum sample). Embryo transfer was performed usually 2 days after the oocyte pick-up when four-cell-stages were noted. At this time as well as 4 and 8 days later serum samples were obtained for measurements of E 2 and progesterone (P) to assess the quality of the luteal phases. For the purpose of this study the data were evaluated according to three different criteria: I. Time relationship between the onset of the LH surge and hcg injection: LH surge starts 1. before, 2. simultaneously with, or 3. after hcg injection. II. Form of the LH surge: A1 rapid increase with maximum/tonus> 4, A2 rapid increase with maximum/tonus < 4, B1 small LH elevation over tonus for some hours before further rapid increase, B2 blunted LH peak with return to baseline before start of rapid increase, C high variation of LH tonus with only one blunted peak. III. Type of follicular E2 curve: Plateau increase 20% to 30%, leap increase 50% to 60%, and steady increase 40% to 50% on the day of LH surge. The definition of E2 response patterns was based on the criteria proposed by Nader et al. 12 who described two different E2 patterns associated with an endogenous LH surge (plateau and leap type). Statistics The data were evaluated by comparison of group means by analysis of variance (ANOVA) and by x2 tests fo:r: frequency analysis where appropriate. Steroid concentrations E2 and P were log-transformed13 before ANOV A. RESULTS Of the 151 patients treated during the study period October 1987 to June 1988, 13% showed no LH increase during CC plus hmg stimulation (Fig. 1), the remainder had LH surges before (20%), concomitant with (23%), or after (44%), the hcg administration. The pregnancy rates in these four groups were not significantly different (25%, 23%, 18%, and 25% of egg collections). The lengths of the follicular phases of the first two groups (surge before hcg injection, and surge simultaneously with hcg injection, days) were significantly shorter than in the others (no increase, and surge after hcg injection, days; P < ). In the 53 cycles studied in detail in this investigation the same tendencies for follicular phase lengths were observed but the differences were not statistically significant. In the majority of cases (73%) the initiation of the LH peak was detected in the morning samples. In these cycles the onset of the LH surge had occurred during late night/early morning (between 10 P.M. and 7:30 A.M.). In only 10% of the cases the surge started later in the morning between 7:30 A.M. and 1:30 P.M., and in 17% in the afternoon to early evening hours. During the study period (October 1987 to June 1988) no clear-cut seasonal changes in the daytime 70 Baukloh et al. Patterns of serum LH surges Fertility and Sterility
3 ~ Ill II Ill IG (,)... :l c 20 0 ;: :I.. ~ Ill 10 i5 :l 11.. (Averige cycle diy of folliculir puncture) Cycle day of follicular puncture LH surge. no increase (n 20) before HCG Injection (n 30) simultaneously to HCG Injection ( n 39) after HCG injection (n 67l Figure 1 Distribution of endogeneous LH surges and average follicular phase length in 151 clomiphene plus hmg-stimulated cycles between October 1987 and June , number of pregnancies; D, average cycle day of follicular puncture. of LH surge onset occurred. However, during the spring months (March to May 1988), 95% of the LH elevations were noted in the early morning hours while during the other months this proportion was significantly lower (61 %; x 2 = , P < 0.025). The subclassification according to the time relationship between hcg injection and onset of the LH surge (criterium I) revealed pregnancy rates not statistically different between subgroups (17%, 17% and 42%, x 2 = , P > 0.1). The same was true for subgroups of different LH patterns (criterium Il-pregnancy rates: 32%, 18%, 0%, 22%, and 100%), and for those of different follicular E2 curves (criterium III-pregnancy rates: 30%, 31%, and21%). LH Parameters The time between the onset of the LH surge and hcg injection was significantly different for subgroups in all three criteria but the time between the LH surge onset and occurrence of the maximum value only differed significantly in I (time relationship between LH surge onset and hcg injection) and II (type of LH surge, Table 1) as did the periods until follicular puncture and insemination of obtained oocytes. The LH tonus and variation (standard deviation [SD]) as well as the maximum value were similar between subgroups of criterium I and III. As expected by the definition of subgroups in II (form of LH surge) all LH parameters were significantly different between groups (Fig. 2A to E). The LH tonus was higher in subgroups A2, B2, and C than in A1 and B1 while the highest variation in LH concentrations was also seen in C. The time between the onset of the LH surge and the occurrence of the maximum value was similar in subgroups B1, B2, and C (22.2, 20.2, and 18.8 hours) and significantly higher than in subgroups A1 and A2 (9.9 and 10.4 hours). Length of Follicular Phases There were no significant differences between the length of follicular phases for any of the criteria analysed. The day on which follicular puncture was performed varied from cycle day 11 to 15 in all subgroups. The evaluation of the follicular E 2 response revealed significant differences up to the day of the LH surge onset between subgroups according to criterium I (Table 2). The E 2 levels for all follicular cycle days were highest in subgroup 3 (LH surge after hcg injection) and lowest in subgroup 2 (LH surge simultaneous with hcg) although the E 2 increase paralleled those seen in subgroup 1 (LH surge onset before hcg). In the subgroups analysed by the type of E 2 response (criterium III) no significant differences in follicular E 2 concentrations were revealed for any day of the cycle. Between subgroups according to criterium II (form oflh surge) significant differences were evident for E 2 levels at all cycle days (Fig. 2A to E). Lowest E 2 levels were seen in subgroups B1 and B2 with a steep increase early in the cycle flattening after the LH surge (Fig. 2C and D). The highest E 2 levels throughout the follicular phase occurred in subgroup C with a steep increase until the LH surge and a slight decrease thereafter. Subgroups A1 and A2 showed intermediate E 2 levels with a flattening curve from the day before the LH surge Baukloh et al. Patterns of serum LH surges 71
4 Table 1 Time Relationships Between Onset of LH Surge and HCG Injection, LH Maximum, Follicular Puncture, and Insemination of Obtained Oocytes in Subgroup II (Type oflh Surge)a Time until A1 A2 (hours) (n = 25) (n = 11) B1 B2 c (n = 5) (n = 9) (n = 3) F HCG injection 3.26 ± ± 4.09 LHmaximum 9.92 ± ± 3.11 Follicular puncture ± ± 2.10 Insemination of oocytes ± ± ± ± ± P< ± ± ± P< ± ± ± P< ± ± ± P<0.005 a Values are means± standard error. onset to the day of LH surge and a further increase thereafter. Number of Obtained Oocytes, Fertilization, and Embryo Transfer Rates No significant differences were observed between any of the subgroups when the number of oocytes obtained, and the rates of fertilization and ETs were compared (data not shown). Five to eight oocytes were inseminated and 43% to 71% of these were transferred as embryos. Likewise there were no differences in the number of transfers with one or two versus transfers with three or more embryos between subgroups of any of the analyzed criteria. Similarly the cell stages observed at the time of ET did not differ between subgroups. Luteal Phases Luteal phase E 2 as well as P concentrations on the day of ET and 4 and 8 days later were not significantly different in subgroupings I (timing oflh surge onset) and III (follicular E 2 increase type). Between subgroups of criterium II (type of LH surge) also no significant differences were seen in luteal phase steroid concentrations. However, the highest concentrations for both E 2 and P were observed in C (E pg/ml, P 139 ng/ml on day 8) and A2 (E pg/ml, P 97 ng/ml on day 8) »... ajatlft 25l LH-max*, """! ~ b ~ ~ ~ Cycle d~y r!(ahye to onset of LH s~rge L.J ~. ' -~ =11-. l ;l ' t)lll~~osi t<0.05 pc0.01 -l l Figure 2 Follicular E 2 and LH levels in five subgroups according to the type of LH surge. A1 rapid increase, maximum/ tonus > 4; A2, rapid increase, maximum/tonus < 4; B1, small LH elevation over tonus before further rapid increase; B2, blunted LH peak, return to baseline before start of rapid in '!rease; C, high variation of LH tonus, only one blunted peak. Comparison of Conception Cycles with those not Resulting in Pregnancy The cycles resulting in pregnancies showed no difference to the "unsuccessful" cycles with regard to follicular or luteal steroid levels as well as follicular serum LH concentrations. A striking difference between the two groups was seen in the time period between the onset of the LH surge and the time of oocyte insemination. This interval was significantly shorter (Fig. 3, F = , P < 0.025) in 12 cycles with intact pregnancies (40.74 hours) and conceptions resulting in early abortions (36.03 hours) than in the 38 cycles not resulting in pregnancy (47.88 hours). The number of embryos transferred was significantly higher in conception cycles (4.2 ± 0.35) than in "no pregnancy" cycles (2.9 ± 0.26; t = , P < 0.01) although the number of obtained oocytes was similar (5.93 ± 0.52 and 5.87 ± 0.37, respectively). Likewise the number of transfers with three or more embryos was higher in the former group (13 of 15 transfers) as compared with the un- 72 Baukloh et al. Patterns of serum LH surges Fertility and Sterility
5 Table 2 Follicular E 2 Response in Subgroup I (Time Relationship Between Onset of LH Surge and HCG Injection) Relative to the Day of LH Surge Onset a Cycle day< LH surgeb (8) 624 (16) 882 (22) 1324 (23) 1859 (23) 2212 (19) (3) 743 (6) 1204 (6) 1386 (6) 2060 (6) (19) 890 (24) 1294 (24) 1719 (24) 2313 (24) F p <0.001 <0.001 <0.001 a Values are geometric means; values in parentheses are number of measurements. b LH surge: 1, before; 2, simultaneously with; 3, after hcg injection <0.050 <0.050 c Cycle day 0 = day of LH surge onset. d NS, not significant NSd successful cycles (21 of 38 cycles) but this difference did not reach statistical significance. DISCUSSION High tonic urinary LH levels during the follicular phase of stimulated cycles have been associated with a reduced chance of pregnancy after IVF.14 This was not verified for serum LH levels in the present study because there were no differences in the LH tonus of pregnancy and no pregnancy cycles after IVF. However, the same group ofinvestigators10 reported an LH tonus of 9.9 ± 1.0 miu /ml in serum of their seven patients treated by the standard stimulation regimen. The highest LH tonus observed in our study was 8.2 miu /ml (mean ± SD: 3.6 ± 1.4 miu /ml) that is still below the level observed in their study. The occurrence of an endogenous LH surge as observed in 64 IVF cycles after CC plus hmg stimulation in this study represented a follicular phase l1meunt11 lh mu1mum tontcular puncture (onsetollhsurge) lniiciiiflgllllltflft t2) o--olboltlollll"'traut l ln ll -I'IOIIfligiiiiiCY(II ll) Figure 3 Intervals between onset of LH surge and time of hcg injection, time until LH maximum, time of follicular puncture and insemination of oocytes in conception and "unsuccessful" IVF cycles. 1 day shorter than expected in comparison with 87 cycles in which ovulation was triggered by hcg injection (Fig. 1). This shorter period of follicular maturation obviously had no detrimental effect on oocyte quality since the pregnancy rates were not different between. exogenously (hcg) and endogenously (LH) triggered cycles. In vitro fertilization cycles resulting in pregnancy were not managed differently from other cycles until oocyte recovery (Fig. 3). Oocytes finally establishing a conception were inseminated about 8 hours earlier in relation to the LH surge onset than oocytes not leading to a pregnancy. Therefore the time oocytes are allowed to mature in vitro in relation to the onset of the LH surge may be more decisive for their fertilizability than the period they are exposed to LH in vivo. The low pregnancy rates in cycles with an endogenous LH discharge reported by other authors4-6 may have been because of problems in the timing ofthe onset of the LH surge. This might be caused by different definitions of a significant LH rise. If LH levels are not determined frequently enough small elevations may be missed resulting in luteinized follicles and overmature oocytes at the time of recovery. Basically three different types of serum LH surges were identified in the 53 cases studied in detail around the time of the expected surge onset until follicular puncture. These subgroups differed in the time periods between onset of the LH surge and the hcg injection, time until the maximum LH value was observed, time until follicular puncture and insemination of oocytes (Table 1). The characteristics of these subgroups were: (A) (A1 and A2), low LH tonus with straight increase after surge onset; (B) (B1 and B2), low tonus with small but significant LH elevation before the start of the real Baukloh et al. Patterns of serum LH surges 73
6 peak; (C), relatively high tonus with large variations but no prominant peak. Nevertheless, these parameters had no influence on the pregnancy rates that were not statistically different between the subgroups. These findings are in good agreement with the results of Macnamee et al.10 who also found three principal types of LH secretion in urine: the biphasic type (corresponding to B2), the plateau type (corresponding to B1), and the sharp rise type (corresponding to A1 and A2). Zech and colleagues15 identified six different patterns of urinary LH in their 55 patients stimulated with CC plus follicle-stimulating hormone (FSH) and reported pregnancies only in cases where there was an LH surge registered either before or after the hcg injection. Interestingly they had no pregnancy in cases with very low, very high, or strongly fluctuating urinary LH levels in which there was also no LH surge observed. This last category seems to correspond with our subgroup C with only blunted serum LH peak and no further increase but in all the three cases of this subgroup pregnancy was established. Although urinary LH levels were not recorded in our study it appears from these findings that serum and urinary LH concentrations are not well correlated in CC plus hmg-stimulated cycles. The follicular E2 concentrations were significantly different in the subgroups of different serum LH patterns (Fig. 2) for any cycle day but not between subgroups divided according to the E2 increase on the day of LH surge onset (criterium III). Therefore it is not the E2 concentration16 but rather the combination of follicle number and growth rate17 in relation to the dynamics of E 2 increase2 12 which seems to be associated with the type of LH surge in CC plus hmg-stimulated cycles. In the present study the plateau type of follicular E2 response was associated in 61% with the A type, in 26% with the B type of LH surge, and all C type LH patterns occurred in this category. Both the leap and steady increase E2 types had appro ximately 75% type A and 25% type B LH surges. The trigger for ovulation by hcg injection may have accelerated the secretion of LH because the maximum value after onset of the LH surge was already observed 7.6 hours later whereas the differences between LH surge onset and maximum were 19.6 hours and 13.9 hours in the other subgroups (data not shown). No significant differences were identified in the luteal phases of LH subgroups stressing the fact that LH secretion does not seem to have a decisive effect after ovulation.18 The important function of LH is to initiate the resumption of oocyte meiosis at the end of the follicular phase. This may be prematurely triggered by high tonic levels or small elevations before the definite onset of the surge14 19 as suggested by subgroup B (B1 and B2) in the present study. Therefore LH concentrations must be closely monitored throughout the follicular phase in every stimulation regimen that does not involve suppression of LH secretion by gonadotropin-releasing hormone analogues.10 An LH surge occurs in the majority of CC plus hmg-stimulated cycles with about 45% starting only after the injection of hcg. Because the type of the LH surge has no effect on the probability of conception the precise identification of the surge onset, if occurring before hcg triggering, is sufficient to allow proper timing of follicular puncture and insemination of oocytes. REFERENCES 1. Ferraretti AP, Garcia JE, Acosta AA, Jones GS: Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women. Fertil Steril 40:7 42, van Uem JFHM, Garcia JE, Liu HC, Rosenwaks Z: Clinical aspects with regard to the occurrence of an endogenous luteinizing hormone surge in gonadotropin-induced normal menstrual cycles. J In Vitro Fert Embryo Transf 3:345, Glasier A, Thatcher SS, Wickings EJ, Hillier SG, Baird DT: Superovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge. Fertil Steril 49: 81, Eibschitz I, Belaisch-Allart JC, Frydman R: In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge. Fertil Steril 45:231, Lejeune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F: In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril 45: 377, Punnonen R, Ashorn R, Vilja P, Heinonen PK, Kujansuu E, Tuohimaa P: Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril 49: 479, Kaplan R, Dekel N, Kraicer PF: Acceleration of onset of oocyte maturation in vitro by luteinizing hormone. Gamete Res 1:59, Templeton AA, Van Look P, Angell RE, Aitken RJ, Lumsden MA, Baird DT: Oocyte recovery and fertilization rates in women at various times after the administration ofhcg. J Reprod Fertil 76:771, Levran D, Lopata A, Nayudu PL, Martin MJ, McBain JC, Bayly CM, Speirs AL, Johnston WIH: Analysis of the outcome of in vitro fertilization in relation to the timing of 74 Baukloh et al. Patterns of serum LH surges Fertility and Sterility
7 human chorionic gonadotropin administration by the duration of estradiol rise in stimulated cycles. Fertil Steril 44: 335, Macnamee MC, Rowles CM, Edwards RG: Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonist. Hum Reprod 2:569, Nader S, Berkowitz AS, Ochs D, Wolf DP, Held B: Incidence of endogenous gonadotropin surges in stimulated cycles in an in vitro fertilization/embryo transfer program. Infertility 11:35, Nader S, Berkowitz AS, Ochs D, WolfDP, Maklad N, Held B: Patterns of estradiol response in patients with endogenous gonadotropin surges during follicular recruitment in an in vitro fertilization and embryo transfer program. Fertil Steril46:448, Okamoto S, Healy DL, Howlett DT, Rogers PAW, Leeton JF, Trounson AO, Wood EC: An analysis of plasma estradiol concentrations during clomiphene citrate-human menopausal gonadotropin stimulation in an in vitro fertilization-embryo transfer program. J Clin Endocrinol Metab 63:736, Rowles CM, MacNamee MC, Edwards RG, Goswamy R, Steptoe PC: Effect of high tonic levels of luteinizing hormone on outcome of in-vitro fertilization. Lancet 2:521, Zech H, Weiss P, Zerlauth M, Fritzsche H: Bedeutung spezifischer LH-Muster vor und nach Ovulationsinduktion mit hcg im Rahmen der In-vitro-Fertilisierung und deren vereinfachte Diagnostik. Geburtsh Frauenheilk 48:404, Vargyas JM, Marrs RP: Endogenous luteinizing hormone release using human menopausal gonadotropins for in vitro fertilisation. J In Vitro Fert Embryo Transf 4:107, Templeton AA, Messinis IE, Baird DT: Characteristics of ovarian follicles in spontaneous and stimulated cycles in which there was an endogenous luteinizing hormone surge. Fertil Steril46:1113, Martikainen H, Riinnberg L, Ruokonen A, Kauppila A: Anterior pituitary dysfunction during the luteal phase following ovarian hyperstimulation. Fertil Steril4 7:446, Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 92:385, 1985 Baukloh et al. Patterns of serum LH surges 75
Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationGonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome
FERTILITY AND STERILITY Copyright e 1993 The American Fertility Society Vol. 59, No.3, March 1993 Printed on acid-free paper in U.S.A. Gonadotropin-releasing hormone agonist reduces the miscarriage rate
More informationProgramming in vitro fertilization for a 5- or 3-day week
Ass~st.d.reproductive tec"no'ogy FERTILITY AND STERILITY Copyright I[J 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Programming in vitro fertilization for a 5- or 3-day week
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationSuperovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge
FERTLTY AND STERLTY Copyright e 1988 The American Fertility Society Printed in U.S.A. Superovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge Anna Glasier, M.D.* Samuel
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationA controlled study of gonadotropin-releasing hormone agonist (buserelin acetate*) for folliculogenesis in routine in vitro fertilization patients
FERTILITY AND STERILITY Copyright" 1991 The American Fertility Society Vol. 56, No. 3, September 1991 Printed on acid-free paper in U.S.A. A controlled study of gonadotropin-releasing hormone agonist (buserelin
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationVery high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization
FERTILITY AND STERILITY Copyright 990 The American Fertility Society Printed on acid-free paper in U.S.A. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization
More informationConception rate after in vitro fertilization in patients who conceived in a previous cycle
FERTILITY AND STERILITY Copyright
More informationPrediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene citrate*
FERTILITY AND STERILITY Copyright 1987 The American Fertility Society Printed in U.8A. Prediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene
More informationIn vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome
Assisted reproductive techno.logy FERTILITY AND STERILITY Vol. 60, No.5, November 1993 Copyright 199a The American Fertility Society Printed on acid-free paper in U. S. A. In vitro fertilization and embryo
More informationSuperovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*
aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationEffect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer cycles*
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationArticle Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
RBMOnline - Vol 13. No 3. 2006 326 330 Reproductive BioMedicine Online; www.rbmonline.com/article/1911 on web 13 June 2006 Article Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationDifferences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation*
FRTILITY AND STRILITY Copyright 0 1986 The American Fertility Society Vol. 46, No.4, October 1986 Printed in U.8A. Differences in ovarian stimulation in human menopausal gonadotropin treated woman may
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationNew York Science Journal 2014;7(4)
The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationMilan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,
FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationSTIMULATION AND OVULATION TRIGGERING
STIMULATION AND OVULATION TRIGGERING Professor IOANNIS E. MESSINIS MD, PhD (Aberdeen, UK), FRCOG (UK) Department of Obs/Gynae University of Thessaly Larissa, GREECE DISCLOSURE Nothing to disclose Learning
More informationThe influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer*
FERTILITY AND STERILITY Copyright 0 1989 The American Fertility Society Printed on acid-free paper in U.S.A. The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro
More informationDepartment of Gynaecology and Reproductive Medicine, University Hospital, University of Western Ontario, London, Ontario, Canada
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationRafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant
More informationLars G.Westergaard 1, Karin Erb, Steen Laursen, Per E.Rasmussen and Sven Rex
Human Reproduction vol.11 no.6 pp. 1209-1213, 19% The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertuization in
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More information(1.,, ) (2.,,, )
33 11 Vol.33 No.11 2013 11 Nov. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.11.0749 E-mail: randc_journal@163.com IVF-ET 1 2 1 1 1 1 1 (1. 510150) (2. 510150) : (COH) (premature
More informationA Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist
1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationResearch and Health Policy Studies, Tufts-New England Medical Center, Boston, Massachusetts
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis Ioannis P. Kosmas, M.D., a Athina
More information(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationUse of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to friendly IVF?
Human Reproduction Vol.17, No.8 pp. 2022 2026, 2002 Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to friendly IVF? J.B.Engel, M.Ludwig 1, R.Felberbaum,
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationOriginal Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI
Int J Clin Exp Med 2016;9(7):14677-14683 www.ijcem.com /ISSN:1940-5901/IJCEM0026636 Original Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI
More informationEffects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization
FERTILITY AND STERILITY Copyright 1990 The American Fertility Society Printed on acid-free paper in U.S.A Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming
More informationRelevance of LH activity supplementation
Relevance of LH activity supplementation in ovulation induction Franco Lisi Servizio di Fisiopatologia della Riproduzione Clinica Villa Europa Roma, Italia Comprehension of the role of LH in follicular
More informationAlternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment
Human Reproduction Vol., No.11 pp. 319 3197, 5 Advance Access publication July 1, 5. doi:.93/humrep/dei Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to
More informationEgg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer
FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization
More informationBulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t
FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women
More informationArticle Effect of cetrorelix dose on premature LH surge during ovarian stimulation
RBMOnline - Vol 16. No 6. 2008 772-777 Reproductive BioMedicine Online; www.rbmonline.com/article/3181 on web 18 April 2008 Article Effect of cetrorelix dose on premature LH surge during ovarian stimulation
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationPoor & Hyper responders: what is the best approach?
Poor & Hyper responders: what is the best approach? A. La Marca ObGyn Dept University of Modena and Reggio Emilia Italy Center for Reproductive Medicine University Hospital of Modena Italy Criteria used
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationSuperovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion
Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion A.S. Leaflet R1362 Acacia A. Alcivar, graduate research assistant,
More informationCigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test*
FERTILITY AND STERILITY Copyright @ 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by
More informationI.E.Messinis 1,4, S.Milingos 1, K.Zikopoulos 2, G.Hasiotis 3, K.Seferiadis 3 and D.Lolis 2
Human Reproduction vol.13 no.9 pp.2415 2420, 1998 Luteinizing hormone response to gonadotrophinreleasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating
More informationUse of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment
FERTILITY AND STERILITY Copyright'" 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene
More informationComplete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles
r FERTILITY AND STERILITY Copyright ~ 1993 The American Fertility Society Printed on acid-free paper in U.S.A. Complete failure of fertilization in couples with unexplained infertility: implications for
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationPituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.
UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.
More informationArticle Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment
RBMOnline - Vol 7. No 2. 185 189 Reproductive BioMedicine Online; www.rbmonline.com/article/900 on web 18 June 2003 Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,
More informationIntercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization*
FERTILITY AND STERILITY Copyright C> 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Inter variability of day 3 follicle-stimulating hormone levels and its effect on stimulation
More informationRisk factors for spontaneous abortion in menotropintreated
FERTILITY AND STERILITY Copyright ~ 1987 The American Fertility Society Vol. 48, No. 4, October 1987 Printed in U.S.A. Risk factors for spontaneous abortion in menotropintreated women Michael Bohrer, M.D.*
More informationRaoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest
Raoul Orvieto The Chaim Sheba Medical Center Tel Hashomer, Israel Declared no potential conflict of interest LH in antagonist cycles; is the story really written? Raoul Orvieto M.D. Israel Overview Role
More informationSerum follicle-stimulating hormone inhibition is a marker for preovulatory oocytes in in-vitro fertilization and embryo transfer
Serum follicle-stimulating hormone inhibition is a marker for preovulatory oocytes in in-vitro fertilization and embryo transfer David Kreiner¹, Joseph Itskovitz, Kathleen Droesch, Daniel Navot, Hung-Ching
More informationDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. The effect of baseline complex ovarian cysts on in vitro fertilization outcome*t Elizabeth A.
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationIVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1
CLINICAL ASSISTED REPRODUCTION IVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1 A. LASS, 2,3 A. GERRARD, 2 N. ABUSHEIKHA, 2 F. AKAGBOSU, 2 and P. BRINSDEN 2 Submitted: April
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationThe Human Menstrual Cycle
The Human Menstrual Cycle Name: The female human s menstrual cycle is broken into two phases: the Follicular Phase and the Luteal Phase. These two phases are separated by an event called ovulation. (1)
More informationTreatment of Poor Responders
Treatment of Poor Responders Pathophysiology of Poor Responders Deficiency in systemic IGF 1 levels (Bahceci, 2007) Lower intra ovarian T levels Reduced FSH receptor expression (Cai, 2007) Bahceci, 2007,
More informationInvestigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?
Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that
More informationArticle Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study
RBMOnline - Vol 15. No 2. 2007 134-148 Reproductive BioMedicine Online; www.rbmonline.com/article/2711 on web 13 June 2007 Article Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationFertility Diagnostics
Fertility Diagnostics Fertility hormones measured on PATHFAST For internal use only Diagnostics PATHFAST Chemiluminescence-immuno-analyzer 1 Content: page 1. Fertility hormones - general aspects 1.1 Reproductive
More informationthat induce morphologic (4, 5) and biochemical (6) endometrial alterations relevant to uterine receptivity.
FERTILITY AND STERILITY VOL. 70, NO. 2, AUGUST 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. 12 Increasing uterine
More informationDaily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles
FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan
More informationOrgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1 1. NAME OF THE MEDICINAL PRODUCT 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 0.25 mg of ganirelix (INN) in 0.5 mg aqueous solution.
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationSuperovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion
Beef Research Report, 1996 Animal Science Research Reports 1997 Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion Acacia
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More information